Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Randomized, Controlled Clinical Study of Ningmitai Capsule to Promote the Passage of Residual Fragments After Ureteroscopic Lithotripsy

NCT06105827 is registered in ClinicalTrials.gov with Xintian Pharmaceutical as lead sponsor.

NCT NCT06105827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06105827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Randomized, Controlled Clinical Study of Ningmitai Capsule to Promote the Passage of Residual Fragments After Ureteroscopic Lithotripsy
Lead sponsor
Xintian Pharmaceutical
Phase
Phase 4
Overall status
Completed
Start date
October 2, 2016
Completion date
April 25, 2019
Enrollment
251 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ureteral calculi